With a robust background as Associate professor and Research assistant professor, my professional journey has been marked by pioneering contributions to biosensor technology and the fight against infectious diseases and many clinical disorders including cancer. Our team's work revolves around developing cutting-edge drug and gene delivery systems, and biosensors with a particular emphasis on the synthesis, characterization, and manipulation of nanoparticles.At the University of Connecticut, our collective efforts have led to innovative solutions for Alzheimer diseases diagnostics using 3D printed microfluidic chips using CRISPR/Cas technology. Throughout my career path, I gained multidisciplinary experience in developing biosensors depending on nucleic acids, and non- coding RNAs, as well as advancements in bacteriophage applications for precise diagnosis and bacterial treatment. The synthesis of my expertise in biochemistry, nano-biotechnology, cell biology culminates in a fervent pursuit of novel, non-invasive biomarkers and targeted treatments that promise to revolutionize healthcare.This is beside my entrepreneurship skills that I have gained from Royal Academy of Engineering (London, UK), and national Academy of science (USA), with the output of established my first start-up Global nano solutions.Briefly, My main interests in developing point of care testings for infectious diseases, and cancer using various nanoparticles, CRISPr/Cas, and 3D printed microfluidic chips, and electrochemistry.